Invicta Diagnostic Share Price

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name Invicta Diagnostic LLP vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre. Further, Invicta Diagnostic LLP converted into a Private Limited Company as Invicta Diagnostic Private Limited dated December 01, 2023. Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to Invicta Diagnostic Limited and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre.Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology andpathology solutions. It offer a onestop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.The business and brand PC Diagnostics were conceptualised and founded by Dr. Ketan Jayantilal Jain and Dr. Sanket Vinod Jain, Promoters and NonExecutive directors, who are a firstgeneration entrepreneur in healthcare and have more than 10 years and 7 years of experience, respectively, in integrated diagnostics business and both are a radiologist. The Promoter and Chief Financial Officer, Rohit Prakash Srivastava, have been involved in our business and operations since 2021 as Management Advisor.The history dates back to 2021, when the Promoters established the first PC Diagnostics Centre in Thane, Maharashtra having the entire gamut of services including PET CT Scans, CT Scans, MRI Scans, Sonography, XRay and Pathology. The test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at their own centres to cytogenetics and highend molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests from basic echocardiograms, Xrays and ultrasounds to advanced radiology tests including computerised tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT (PET CT).The Company acquired majority shareholding in PCD Diagnostics LLP for a fullfledged diagnostic centre in Marol, Andheri East, forming it as the subsidiary in 2023. Thereafter, it acquired majority shareholding in Primacare Healthcare LLP for a fullfledged diagnostic centre in Byculla, forming it as subsidiary and further acquired majority shareholding in Pratham MRI and CT Scan Centre for a fullfledged diagnostic centre in Bhayandar, forming it a subsidiary in 2023. In 2024, the Company acquired a diagnostic centre in Sewri from PCD Medical LLP, acquired a diagnostic centre in Parel from Primacare Diagnostic LLP and acquired a centralised laboratory in Parel from Porteus Path Lab LLP. The Company further formed Invicta Medical LLP as a subsidiary for setting up of diagnostic centre in Kalwa, Thane in 2024.In FY 2025, Company acquired Porteus Medical LLP, Primacare Diagnostic LLP, for setting up of a diagnostic centre in Dadar, Mumbai, making it a subsidiary of the Company. The Company came up with its initial public offering by issuing 33,08,000 equity shares of Rs 10 each by raising Rs 28.12 crores in December 2025.

For the full year FY2025–2026, revenue reached ₹30.66 crore and profit touched at ₹4.69 crore.

As of 20 Jan 2026, Invicta Diagnostic share price is ₹66. The stock opened at ₹71.5 and had closed at ₹74.4 the previous day. During today’s trading session, Invicta Diagnostic share price moved between ₹66.05 and ₹71.50, with an average price for the day of ₹68.78. Over the last 52 weeks, the stock has recorded a low of ₹64.00 and a high of ₹105.00. In terms of performance, Invicta Diagnostic share price has declined by 22.3% over the past six months and has declined by 24.51% over the last year.